Cytek Biosciences, Inc. financial data

Symbol
CTKB on Nasdaq
Location
47215 Lakeview Boulevard, Fremont, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q1 2025 - May 8, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 619 % -14.8%
Quick Ratio 74.3 % -32.9%
Debt-to-equity 26.3 % +5.25%
Return On Equity -1.39 % -116%
Return On Assets -1.13 % -106%
Operating Margin -11.8 % +90.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 127M shares -3.52%
Common Stock, Shares, Outstanding 128M shares -2.79%
Entity Public Float 670M USD -35%
Common Stock, Value, Issued 128K USD -2.29%
Weighted Average Number of Shares Outstanding, Basic 128M shares -1.97%
Weighted Average Number of Shares Outstanding, Diluted 128M shares -1.97%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 201M USD +813%
Revenue from Contract with Customer, Excluding Assessed Tax 197M USD -1.86%
Research and Development Expense 39.3M USD -10.6%
Selling and Marketing Expense 49.1M USD -2.9%
General and Administrative Expense 44.6M USD +3.01%
Operating Income (Loss) -24.8M USD +6.26%
Nonoperating Income (Expense) 16.8M USD +56.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -7.97M USD +49.1%
Income Tax Expense (Benefit) 3.28M USD
Net Income (Loss) Attributable to Parent -11.4M USD -84.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 95.3M USD -43.5%
Accounts Receivable, after Allowance for Credit Loss, Current 55M USD +9.39%
Inventory, Net 45.3M USD -17.2%
Other Assets, Current 2.29M USD -8.2%
Assets, Current 381M USD -2.1%
Property, Plant and Equipment, Net 17.8M USD -2.26%
Operating Lease, Right-of-Use Asset 9.87M USD -0.8%
Intangible Assets, Net (Excluding Goodwill) 19.4M USD -12.7%
Goodwill 16.7M USD +3.06%
Other Assets, Noncurrent 4.57M USD +12.1%
Assets 483M USD -1.93%
Accrued Liabilities, Current 19.2M USD +6.33%
Contract with Customer, Liability, Current 27.7M USD -27.4%
Liabilities, Current 67.7M USD +21.8%
Contract with Customer, Liability, Noncurrent 15.7M USD
Operating Lease, Liability, Noncurrent 7.45M USD -14.4%
Other Liabilities, Noncurrent 2.38M USD +30.3%
Liabilities 103M USD +3.54%
Accumulated Other Comprehensive Income (Loss), Net of Tax -609K USD +60.8%
Retained Earnings (Accumulated Deficit) -46.6M USD -31.8%
Stockholders' Equity Attributable to Parent 380M USD -3.31%
Liabilities and Equity 483M USD -1.93%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -125K USD -103%
Net Cash Provided by (Used in) Financing Activities -11.5M USD -816%
Net Cash Provided by (Used in) Investing Activities 9.45M USD
Common Stock, Shares Authorized 1B shares 0%
Common Stock, Shares, Issued 128M shares -2.79%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.45M USD -328%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 95.3M USD -43.7%
Deferred Tax Assets, Valuation Allowance 2.8M USD +23.5%
Deferred Tax Assets, Gross 38.8M USD +7.75%
Operating Lease, Liability 11M USD +0.09%
Depreciation 3.6M USD +16.1%
Payments to Acquire Property, Plant, and Equipment 849K USD +49.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -10.3M USD +17.4%
Lessee, Operating Lease, Liability, to be Paid 11.6M USD +0.25%
Property, Plant and Equipment, Gross 27.5M USD +12.6%
Operating Lease, Liability, Current 3.54M USD +55.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.66M USD +6.39%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.04M USD +19.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure +37%
Deferred Income Tax Expense (Benefit) -336K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 645K USD +3.04%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.21M USD -4.58%
Deferred Tax Assets, Operating Loss Carryforwards 1.61M USD +13.9%
Unrecognized Tax Benefits 3.6M USD -0.99%
Lessee, Operating Lease, Liability, to be Paid, Year Four 514K USD -74.9%
Additional Paid in Capital 427M USD -0.62%
Amortization of Intangible Assets 3.7M USD +2.78%
Depreciation, Depletion and Amortization 1.88M USD +10.4%
Deferred Tax Assets, Net of Valuation Allowance 36M USD +6.69%
Share-based Payment Arrangement, Expense 27.8M USD +21.1%
Interest Expense 1.84M USD -30.8%